Community Shares | July 8th 2024
A new review has investigated the potential use of immunomodulating agents to treat neuroinflammation in patients with autism, who often do not respond to standard treatments. Neuroinflammation, influenced by genetic, epigenetic, and environmental factors, is considered a significant contributor to ASD. This work highlights that some existing anti-inflammatory treatments have shown promise, including corticosteroids, intravenous […]
Community Shares | June 24th 2024
This week’s articles: Neuroscientists have developed an advanced brain mapping method using virtual reality (VR) and artificial intelligence (AI) to create detailed 3D visual timelines of neuron development in newborn mice; A new validation study has evaluated the accuracy of clinical diagnosis codes in identifying childhood psychiatric and neurodevelopmental conditions using electronic health records (EHR) from an extensive, diverse healthcare system; The U.S. Supreme Court has decided not to hear Pitta v. Medeiros, a case that concerns whether parents can record meetings with their child’s school district about special education services; Autism Research Institute’s (ARI) new webinar “Blood-Brain Barrier Dysfunction in Pediatric Acute Neuropsychiatric Syndrome.”
Register for Autism Research Institute’s Newest Webinar
So much has changed with the COVID-19 pandemic, and its been especially hard on our children, friends, and clients on the spectrum who thrive on routine and predictability. Many have learned to self-regulate through physical outlets that have been limited or may no longer be available.
